Venker Eric — SEC Form 4 filings
SEC reporting owner CIK 1801917. 48 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 48 filings on record, filed 2024-01-23 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 48 legs across 32 filings — 9,282,509 shares, $156,085,737 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 130.
- Largest priced transaction: sale of 683,818 shares @ $14.95 ($10,223,079) in Roivant Sciences Ltd., filed 2025-09-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | 44 | — | 45 legs · 9,265,188 sh · $155,623,903 | 119 |
| Immunovant, Inc. (IMVT) | Chief Executive Officer, Director | 4 | — | 3 legs · 17,321 sh · $461,834 | 11 |
Form 4 filings — Venker Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 166,182 @ $35.63 · Sale (S): 33,818 @ $36.44 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-08-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 13,909 @ $36.84 | EDGAR |
| 2026-07-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $34.95 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 92,188 @ $14.46 · Disposition to issuer (D): 86,629 @ $38.14 · Sale (S): 3,092 @ $38.48 · Option exercise (M): 92,188 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 153,766 @ $33.05 · Sale (S): 46,234 @ $33.51 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 34,483 @ $32.41 · Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $30.27 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $29.59 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 232,252 @ $0 · Grant/award (A): 336,043 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Immunovant, Inc. (IMVT) | Option exercise (M): 368,750 @ $14.46 · Disposition to issuer (D): 334,960 @ $25.10 · Sale (S): 12,820 @ $24.04 · Sale (S): 1,409 @ $24.60 · Option exercise (M): 368,750 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $28.24 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 7,051 @ $27.15 | EDGAR |
| 2026-02-18 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $26.49 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $21.92 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 313,841 @ $3.85 · Sale (S): 200,000 @ $22.45 · Option exercise (M): 117,848 @ $3.85 · Sale (S): 75,000 @ $22.53 · Option exercise (M): 313,841 (derivative) @ $0 · Option exercise (M): 117,848 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $20.85 · Option exercise (M): 200,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 7,051 @ $20.27 | EDGAR |
| 2025-11-07 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 200,000 @ $3.85 · Sale (S): 200,000 @ $20.22 · Option exercise (M): 200,000 (derivative) @ $20.22 | EDGAR |
| 2025-10-17 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 414,683 @ $15.85 · Sale (S): 414,683 @ $16.93 · Option exercise (M): 318,282 @ $15.85 · Sale (S): 318,282 @ $17.05 · Option exercise (M): 118,418 @ $15.85 · Sale (S): 118,418 @ $17.06 · +3 more | EDGAR |
| 2025-10-14 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 104,940 @ $15.85 · Sale (S): 104,940 @ $16.30 · Option exercise (M): 20,727 @ $15.85 · Sale (S): 20,727 @ $16.25 · Option exercise (M): 104,940 (derivative) @ $0 · Option exercise (M): 20,727 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 127,355 @ $15.85 · Option exercise (M): 24,900 @ $7.45 · Option exercise (M): 19,141 @ $3.85 · Sale (S): 171,396 @ $16.34 · Option exercise (M): 67,171 @ $15.85 · Option exercise (M): 107,131 @ $7.45 · +13 more | EDGAR |
| 2025-09-23 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 1,000,000 @ $3.85 · Sale (S): 683,818 @ $14.95 · Option exercise (M): 462,374 @ $3.85 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 316,182 @ $14.99 · Sale (S): 100,000 @ $15.01 · +4 more | EDGAR |
| 2025-08-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 7,051 @ $11.72 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.72 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-08-01 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 198,413 @ $0 | EDGAR |
| 2025-07-30 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 1,300,000 (derivative) @ $0 · Grant/award (A): 189,900 (derivative) @ $0 · Grant/award (A): 1,475,000 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.52 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.45 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 600,000 @ $3.85 · Sale (S): 433,722 @ $11.07 · Option exercise (M): 785,026 @ $3.85 · Sale (S): 566,278 @ $11.22 · Option exercise (M): 600,000 (derivative) @ $0 · Option exercise (M): 785,026 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 39,148 @ $11.04 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $10.95 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $10.15 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $10.22 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $10.97 · Option exercise (M): 400,000 @ $3.85 · Sale (S): 315,522 @ $11.06 · Option exercise (M): 602,311 @ $3.85 · Sale (S): 434,478 @ $10.82 · Option exercise (M): 400,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-02-24 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $10.65 · Tax withholding (F): 10,945 @ $10.72 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 300,000 @ $3.85 · Sale (S): 217,384 @ $10.53 · Option exercise (M): 300,000 @ $3.85 · Sale (S): 218,041 @ $10.42 · Option exercise (M): 300,000 (derivative) @ $0 · Option exercise (M): 300,000 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 8,682 @ $11.15 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.28 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 250,000 @ $3.85 · Sale (S): 176,900 @ $11.82 · Option exercise (M): 250,000 @ $3.85 · Sale (S): 177,704 @ $11.54 · Option exercise (M): 250,000 (derivative) @ $0 · Option exercise (M): 250,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $11.57 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.49 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $11.49 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.32 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $11.92 · Option exercise (M): 100,000 @ $3.85 · Sale (S): 100,000 @ $11.65 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $11.97 | EDGAR |
| 2024-08-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,947 @ $11.48 | EDGAR |
| 2024-07-30 | 4 | Roivant Sciences Ltd. (ROIV) | Grant/award (A): 204,000 @ $0 · Grant/award (A): 409,000 (derivative) @ $0 | EDGAR |
| 2024-07-25 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $11 | EDGAR |
| 2024-06-24 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 10,945 @ $10.80 | EDGAR |
| 2024-05-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 16,003 @ $11.37 | EDGAR |
| 2024-04-23 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 16,002 @ $10.46 | EDGAR |
| 2024-03-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 16,003 @ $10.01 | EDGAR |
| 2024-02-22 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 16,002 @ $11.54 | EDGAR |
| 2024-02-09 | 4 | Roivant Sciences Ltd. (ROIV) | Option exercise (M): 96,950 @ $3.85 · Sale (S): 96,950 @ $10.92 · Option exercise (M): 96,950 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Roivant Sciences Ltd. (ROIV) | Tax withholding (F): 12,377 @ $10.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801917 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →